Current clinical and bacteriological profile of septic arthritis in young infants: a prospective study from a tertiary referral centre

Eur J Orthop Surg Traumatol. 2018 May;28(4):573-578. doi: 10.1007/s00590-018-2142-x. Epub 2018 Feb 9.

Abstract

Purpose: The study was carried out to evaluate the clinical and bacteriological profile of SA in young infants (age ≤ 3 months) in a tertiary referral centre and to assess the risk factors and to document the changing trends in the epidemiology.

Methods: This was a prospective descriptive study on all young infants with SA. Clinical and perinatal history, examination, radiological and laboratory findings (blood count, ESR, CRP, blood and joint cultures) were studied. Emergency arthrotomy was done and antibiotics were administered in all patients.

Result: Thirty young infants were included with a mean age of 22 ± 13.6 days and with male-to-female ratio 1.5:1. Pseudoparalysis and pain were the most common presenting symptoms. Knee joint was most commonly involved followed by hip. Ultrasound of the joint (86%) and elevated CRP levels (97%) were found to be reliable diagnostic markers. Most common causative organism was methicillin-resistant Staphylococcus aureus (43.3%) followed by Klebsiella pneumonia (23%). Sensitivity to empirical antibiotic regimen was lower (ceftriaxone 53%, amoxicillin 35%) when compared to higher antibiotics (gentamycin 88%, vancomycin 100%). Prematurity (57%), low birthweight (73%), anaemia (80%), previous history of hospitalisation (93%) and invasive procedures (90%) were found to be important risk factors.

Conclusion: The disease has distinct regional variations, and the epidemiological and bacterial profile is constantly changing. There is a shift in causative organisms towards more resistant and gram-negative species. Prematurity, low birthweight and previous hospitalisation are the major predisposing factors. A better understanding of the varied presentations is necessary for an early diagnosis and treatment, which is the most important prognostic factor.

Keywords: Joint; Knee; Low birthweight; MRSA; Neonate; Osteomyelitis.

MeSH terms

  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use*
  • Arthritis, Infectious / microbiology*
  • Ceftriaxone / therapeutic use
  • Female
  • Gentamicins / therapeutic use
  • Hip Joint / microbiology
  • Humans
  • Infant
  • Infant, Newborn
  • Klebsiella Infections / drug therapy
  • Klebsiella pneumoniae / isolation & purification
  • Knee Joint / microbiology
  • Male
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Osteomyelitis / drug therapy
  • Osteomyelitis / microbiology
  • Prospective Studies
  • Staphylococcal Infections / drug therapy
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Vancomycin
  • Ceftriaxone
  • Amoxicillin